Published in World J Transplant on December 24, 2016
Current evidence on vitamin D deficiency and kidney transplant: What's new? Rev Endocr Metab Disord (2017) 0.75
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Alemtuzumab induction in renal transplantation. N Engl J Med (2011) 4.13
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. Lancet (2014) 4.05
A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation (2010) 2.90
A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant (2008) 2.81
Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation (2010) 2.57
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant (2008) 2.14
Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation (2006) 1.81
Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant (2005) 1.78
A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg (2008) 1.74
Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation (2000) 1.71
Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol (2012) 1.69
Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis (1999) 1.46
Noncompliance in organ transplant recipients. Transplantation (1990) 1.20
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation (2005) 1.17
Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol (1993) 1.17
Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant (2007) 1.02
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant (2005) 1.00
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant (2010) 0.99
Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation. Nephrol Dial Transplant (2009) 0.99
Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant (2003) 0.98
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol (2002) 0.95
A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant (2009) 0.93
Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc (2001) 0.91
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Transplantation (2007) 0.89
Steroid side effects and their impact on transplantation outcome. Transplantation (2001) 0.87
Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression. Transplantation (2012) 0.86
Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation (2011) 0.82
Osteoporosis after solid organ transplantation. Minerva Endocrinol (2012) 0.79